Magnetic Particles and Static Fields Aid Bone Repair

Published in Discover Nano, the study demonstrates that a composite material named F-Fe3O4, when combined with a static magnetic field, enhances the repair of infected bone tissue in rat models. The approach addresses a significant clinical challenge where standard therapies often fail to balance infection control with the regenerative needs of damaged bone. By integrating magnetic responsiveness with antibacterial and osteogenic functions, the system offers a potential strategy for managing complex orthopedic and stomatological injuries that are difficult to heal with conventional antibiotics and grafts.

The core of the therapeutic system is a multilayered magnetic particle built from iron oxide, or Fe3O4, modified with poly(acrylic acid), magnesium ions, polydopamine, copper oxide, and chitosan. This hierarchical structure allows the particles to be directed to specific sites using an external magnetic field while providing a surface that supports cell adhesion and inhibits bacterial growth. The researchers selected this specific combination of materials to create a platform that could sustain local concentrations of therapeutic agents in poorly vascularized infection sites. Unlike passive diffusion methods, the magnetic properties of the core enable the particles to be concentrated at the target region, which is particularly advantageous for deep or anatomically complex defects where maintaining effective drug levels is challenging.

In vitro experiments using human bone marrow-derived mesenchymal stem cells, or hBMSCs, revealed that the F-Fe3O4 particles exhibited good biocompatibility and promoted cell proliferation, migration, and osteogenic differentiation. When a static magnetic field of approximately 100 millitesla was applied, these effects were further enhanced. The cells in the combined treatment group showed greater viability and more pronounced cytoskeletal organization compared to groups treated with particles alone or control media. This suggests that the static magnetic field acts as an additional physical stimulus that amplifies the biological activity of the magnetic particles, facilitating the cellular processes necessary for tissue regeneration without inducing cytotoxic damage.

The antibacterial performance of the composite particles was tested against three common pathogens associated with bone infections: Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis. The F-Fe3O4 particles significantly inhibited the growth of all three bacterial strains, with the addition of the static magnetic field leading to even lower bacterial viability. In the combined treatment group, the viability of E. coli, S. aureus, and E. faecalis was reduced to approximately 3.78%, 10.43%, and 3.99%, respectively. Scanning electron microscopy images showed that the bacteria exposed to the particles and magnetic field exhibited roughened, shrunken surfaces and morphological deformation, indicating that the treatment disrupts bacterial integrity and leads to cell death.

To evaluate the therapeutic potential in a living system, the researchers created an infectious femoral defect model in rats. The defects were induced by drilling holes in the femur and injecting Staphylococcus aureus to simulate an infected bone injury. The F-Fe3O4 particles were loaded into an injectable methacrylate gelatin hydrogel, which served as a carrier to deliver and retain the particles at the defect site. One week after the procedure, the group treated with both the particles and the static magnetic field showed the lowest bacterial survival rates and the least inflammatory cell infiltration in the surrounding soft tissue. This early-stage antibacterial effect was crucial for preventing the progression of infection and creating a favorable environment for bone healing.

Micro-computed tomography scans performed at four and eight weeks post-operation revealed that the combined treatment group achieved the highest bone volume and the most continuous new bone formation. The defects in the F-Fe3O4 plus static magnetic field group were largely bridged by new bone, whereas the control groups showed discontinuous and irregular bone margins. Quantitative analysis indicated that the new bone volume to total tissue volume ratio, as well as trabecular number and thickness, were significantly higher in the combined treatment group. Histological staining further confirmed that the bone tissue in this group was more organized and mature, with denser collagen fibers and higher expression of osteocalcin, a marker of late-stage osteogenic differentiation.

RNA sequencing and subsequent verification experiments identified the molecular mechanisms underlying the enhanced osteogenic response. The study found that the combined treatment upregulated the expression of SLC2A1, a gene encoding a glucose transporter, which increased glucose uptake and metabolism in the stem cells. This metabolic shift activated the HIF-1 and PI3K/AKT signaling pathways, which are critical for regulating cell survival, growth, and differentiation. By knocking down SLC2A1 or inhibiting these pathways, the researchers demonstrated that the osteogenic effects of the treatment were dependent on this specific signaling cascade. The activation of these pathways ultimately led to the upregulation of RUNX2, a master transcription factor for osteoblast differentiation, thereby accelerating the formation of new bone tissue.

The study also assessed the biosafety of the magnetic particles by examining major organs, including the heart, liver, spleen, lung, and kidney, at one, four, and eight weeks. Hematoxylin-eosin staining of these tissues revealed no evident pathological changes or morphological abnormalities, indicating that the particles did not cause acute systemic toxicity or significant inflammatory responses in vital organs. This favorable biosafety profile supports the potential translational application of the material, although long-term safety evaluations will be necessary to fully understand the fate of the particles and their degradation products over extended periods.

Despite the promising results, the researchers acknowledged several limitations in the study design. The in vivo antibacterial assessment was limited to the early stage of infection, and it remains unclear whether the treatment can guarantee long-term bacterial eradication or prevent persistent low-level infections. Additionally, the spatial uniformity of the static magnetic field in the animal cages was not systematically characterized, meaning that individual rats may have experienced variable field strengths depending on their position. The study also did not include a static magnetic field-only control group, which makes it difficult to distinguish the independent effects of the magnetic field from its synergistic interaction with the magnetic particles.

Future research will need to address these gaps by conducting longer-term microbiological monitoring and investigating the immunomodulatory effects of the particles on the local bone microenvironment. The researchers also plan to optimize the fabrication process to reduce particle aggregation and to systematically evaluate different magnetic field parameters, such as intensity and exposure duration, to establish clearer relationships between physical stimuli and biological outcomes. Validation in large animal models will be essential to assess the durability and safety of the treatment for potential clinical use. This study provides a foundational framework for understanding how multifunctional magnetic materials can be engineered to treat infectious bone defects by coordinating antibacterial and regenerative functions.

Subject of Research: Multifunctional composite magnetic particles combined with static magnetic field for treating infectious bone defects via SLC2A1-mediated HIF-1 and PI3K/AKT pathways

Article Title: Multifunctional composite magnetic particles combined with static magnetic field for treating infectious bone defects via SLC2A1-mediated HIF-1 and PI3K/AKT pathways

Article References: Huang, M., Li, Y., Qin, L., Gao, X., Tang, Y., Huang, T.-Y., Han, J., & Hu, M. (2026). Multifunctional composite magnetic particles combined with static magnetic field for treating infectious bone defects via SLC2A1-mediated HIF-1 and PI3K/AKT pathways. Discover Nano, 21(1), Article 582. https://doi.org/10.1186/s11671-026-04923-w

Image Credits: AI Generated

DOI: 10.1186/s11671-026-04923-w

Keywords: Multifunctional, composite, magnetic, particles, combined, static, field, treating, infectious, bone, defects, SLC2A1-mediated